13.00
price down icon2.48%   -0.33
after-market アフターアワーズ: 13.00
loading
前日終値:
$13.33
開ける:
$13.14
24時間の取引高:
977.46K
Relative Volume:
1.47
時価総額:
$158.33M
収益:
$1.54M
当期純損益:
$-38.70M
株価収益率:
-1.1818
EPS:
-11
ネットキャッシュフロー:
$-36.86M
1週間 パフォーマンス:
-13.79%
1か月 パフォーマンス:
-19.15%
6か月 パフォーマンス:
-69.53%
1年 パフォーマンス:
+150.00%
1日の値動き範囲:
Value
$12.93
$13.46
1週間の範囲:
Value
$12.90
$15.00
52週間の値動き範囲:
Value
$5.0877
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
名前
Corbus Pharmaceuticals Holdings Inc
Name
セクター
Healthcare (1176)
Name
電話
617-963-0103
Name
住所
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
職員
19
Name
Twitter
@corbuspharma
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
CRBP's Discussions on Twitter

CRBP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
13.00 158.33M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-02 開始されました Piper Sandler Overweight
2024-07-30 開始されました Wedbush Outperform
2024-07-22 再開されました H.C. Wainwright Buy
2024-06-26 開始されました B. Riley Securities Buy
2024-06-03 繰り返されました Oppenheimer Outperform
2024-05-13 開始されました RBC Capital Mkts Outperform
2024-03-06 アップグレード Jefferies Hold → Buy
2020-09-08 ダウングレード BTIG Research Buy → Neutral
2020-09-08 ダウングレード Jefferies Buy → Hold
2020-09-08 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-09-08 ダウングレード ROTH Capital Buy → Neutral
2020-07-07 開始されました ROTH Capital Buy
2020-06-17 開始されました BTIG Research Buy
2020-03-26 開始されました Nomura Buy
2019-04-05 開始されました Jefferies Buy
2019-03-20 開始されました Oppenheimer Outperform
2019-01-11 繰り返されました Cantor Fitzgerald Overweight
2018-12-26 開始されました H.C. Wainwright Buy
2018-12-07 開始されました RBC Capital Mkts Outperform
2018-10-24 開始されました B. Riley FBR Buy
2018-01-19 開始されました Raymond James Outperform
2017-12-14 繰り返されました Cantor Fitzgerald Overweight
2017-11-08 繰り返されました Noble Financial Buy
2017-09-29 再開されました Noble Financial Buy
2017-03-30 繰り返されました Cantor Fitzgerald Overweight
2016-11-15 繰り返されました JMP Securities Mkt Outperform
2016-11-11 繰り返されました Noble Financial Buy
すべてを表示

Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース

pulisher
Dec 19, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $62.00 - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

(CRBP) Investment Report - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Dec 18, 2024
pulisher
Dec 17, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Dec 17, 2024
pulisher
Dec 17, 2024

Mizuho remains bullish on Corbus stock, sees encouraging outlook for Nectin-4 ADC - Investing.com Canada

Dec 17, 2024
pulisher
Dec 17, 2024

Charles Schwab Investment Management Inc. Buys 64,800 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Dec 16, 2024
pulisher
Dec 16, 2024

Corbus Pharmaceuticals' SWOT analysis: stock's potential in cancer and obesity - Investing.com

Dec 16, 2024
pulisher
Dec 13, 2024

Corbus Pharmaceuticals Holdings Inc. stock remains steady Friday, underperforms market - MarketWatch

Dec 13, 2024
pulisher
Dec 12, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 12, 2024
pulisher
Dec 10, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 10, 2024
pulisher
Dec 10, 2024

Corbus begins phase 1 trial for advanced solid tumors By Investing.com - Investing.com South Africa

Dec 10, 2024
pulisher
Dec 09, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Dec 09, 2024
pulisher
Dec 09, 2024

Corbus begins phase 1 trial for advanced solid tumors - Investing.com

Dec 09, 2024
pulisher
Dec 09, 2024

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors - The Manila Times

Dec 09, 2024
pulisher
Dec 09, 2024

Corbus Pharmaceuticals Announces Dosing of First Patient in - GlobeNewswire

Dec 09, 2024
pulisher
Dec 09, 2024

Corbus Pharma Launches Phase 1 Trial for Novel Cancer Immunotherapy CRB-601 - StockTitan

Dec 09, 2024
pulisher
Dec 08, 2024

2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential - MSN

Dec 08, 2024
pulisher
Dec 08, 2024

Eli Lilly and Company (LLY-N) QuotePress Release - The Globe and Mail

Dec 08, 2024
pulisher
Dec 08, 2024

Trading (CRBP) With Integrated Risk Controls - Stock Traders Daily

Dec 08, 2024
pulisher
Dec 08, 2024

Walleye Capital LLC Sells 113,428 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 08, 2024
pulisher
Dec 04, 2024

Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey

Dec 04, 2024
pulisher
Dec 04, 2024

FDA fast tracks Corbus drug for cervical cancer treatment By Investing.com - Investing.com Canada

Dec 04, 2024
pulisher
Dec 04, 2024

Corbus Pharmaceuticals' CRB-701 Receives FDA Fast Track Designation for Metastatic Cervical Cancer Treatment - Marketscreener.com

Dec 04, 2024
pulisher
Dec 03, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 03, 2024
pulisher
Dec 03, 2024

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

Dec 03, 2024
pulisher
Dec 03, 2024

Piper Sandler Initiates Coverage of Corbus Pharmaceuticals Holdings (CRBP) with Overweight Recommendation - MSN

Dec 03, 2024
pulisher
Dec 03, 2024

HighVista Strategies LLC Acquires 36,499 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

FDA fast tracks Corbus drug for cervical cancer treatment - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer - GlobeNewswire

Dec 03, 2024
pulisher
Dec 03, 2024

Corbus Pharma Secures FDA Fast Track Status for Cancer Drug CRB-701 - StockTitan

Dec 03, 2024
pulisher
Dec 02, 2024

CRBP (Corbus Pharmaceuticals Holdings) Financial Strength : 8 (As of Sep. 2024) - GuruFocus.com

Dec 02, 2024
pulisher
Dec 02, 2024

Corbus Pharmaceuticals stock rated Overweight, CRB-701 could drive solid tumor efficacy - Investing.com Canada

Dec 02, 2024
pulisher
Dec 02, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch

Dec 02, 2024
pulisher
Dec 02, 2024

Corbus, Viking initiated at overweight by Piper Sandler (NASDAQ:VKTX) - Seeking Alpha

Dec 02, 2024
pulisher
Dec 02, 2024

CRBP (Corbus Pharmaceuticals Holdings) Enterprise Value : $61.43 Mil (As of Dec. 02, 2024) - GuruFocus.com

Dec 02, 2024
pulisher
Nov 30, 2024

Victory Capital Management Inc. Boosts Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Nov 30, 2024
pulisher
Nov 28, 2024

Acuta Capital Partners LLC Reduces Stock Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Nov 28, 2024
pulisher
Nov 26, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

Nov 26, 2024
pulisher
Nov 26, 2024

Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now - Insider Monkey

Nov 26, 2024
pulisher
Nov 25, 2024

CRBP (Corbus Pharmaceuticals Holdings) Change In Working Ca - GuruFocus.com

Nov 25, 2024
pulisher
Nov 24, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 24, 2024
pulisher
Nov 22, 2024

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference - Investing.com Australia

Nov 22, 2024
pulisher
Nov 21, 2024

CRBPCorbus Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Corbus Pharmaceuticals to Present at Evercore HealthCONx Conference in December | CRBP Stock News - StockTitan

Nov 21, 2024

Corbus Pharmaceuticals Holdings Inc (CRBP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):